Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

The Life After Stopping Tyrosine Kinase Inhibitors Study (The LAST Study)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT02269267
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:39:17.305446+00:00
Published At
2023-03-01T00:00:00+00:00
Record Updated At
2023-03-03
Results Posted At
2023-03-01
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Leukemia, Myeloid, Chronic"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-03-03"
protocolSection.identificationModule.nctId
"NCT02269267"
protocolSection.identificationModule.officialTitle
"The Life After Stopping Tyrosine Kinase Inhibitors Study (The LAST Study)"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2023-03-01"

Study condition terms

  • Leukemia, Myeloid, Chronic (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.